Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NK-tumor recognition protein (NKTR) is a membrane-anchored protein encoded by the NKTR gene, characterized by a hydrophobic N-terminal domain and a cyclophilin-like peptidyl-prolyl cis-trans isomerase domain[5]. It is present on the surface of natural killer (NK) cells, where it facilitates their binding to target cells, an essential step in NK cell-mediated cytotoxicity. NKTR expression is upregulated by interleukin-2 activation, emphasizing its role in immune regulation. While the protein participates in the recognition and elimination of tumor and virus-infected cells, there is limited direct evidence implicating NKTR as a therapeutic target or biomarker; much more research has focused on broader families of NK cell receptors (such as KIRs, NKG2D, and NCRs)[1][2][3][4]. NKTR’s molecular function is associated with immune surveillance, innate immunity, and modulation of NK cell-target interactions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NK-tumor recognition protein (NKTR).